98
Views
8
CrossRef citations to date
0
Altmetric
Biological Chemistry

Immunological Properties and Constituent Amino Acids of Three Xylanases Produced Inductively from Streptomyces sp.

, &
Pages 3409-3413 | Received 22 Mar 1985, Published online: 09 Sep 2014
 

Abstract

Three xylanases produced inductively by methyl β-xyloside from Streptomyces sp. No. 3137 were purified to homogeneity. Rabbit antisera against two xylanases, X-I and X-II-B, were prepared.

In double diffusion experiments, antiserum to X-I (anti-I serum) and antiserum to X-II-B (anti-II-B serum) formed a precipitation band with X-I, and X-II-B, respectively. No immunoprecipitate, however, was observed when xylanase X-II-A or X-II-B was tested against anti-I serum, and when X-I was done against anti-II-B serum. Anti-II-B serum formed a line of identity between X-II-A and X-II-B. The data indicate that X-II-A and X-II-B are closely related in immunology, while X-I is distinct.

The amino terminals were an alanine residue for X-I and threonine residues for X-II-A and X-II-B by the dansyl chloride method. The carboxyl terminals were an aspartic acid residue for X-I and an alanine residue for X-II-B by carboxypeptidase Y method.

Amino acid analysis showed that X-II-A and X-II-B had a large amount of glutamic acid and alanine residues, and a small amount of tyrosine, threonine, and serine residues compared with X-I.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.